Novartis’ Exforge To Launch By End Of June
This article was originally published in The Pink Sheet Daily
Executive Summary
Launch timeframe for the combination of firm’s Diovan and Pfizer’s Norvasc is a few months earlier than previously expected due to recent invalidation of Norvasc patent.